硬化肌肉性心肌炎与严重的二次 mitra 反成功地用跨导管边缘到边缘修复治疗:一个病例报告
Daisuke Sato1, Tomoki Ochiai1, Takashi Matsumoto1
1Department of Cardiology, Shonan Kamakura General Hospital, 1370-1, Okamoto, Kamakura City, Kanagawa 247-8533, Japan.
European heart journal. Case reports
|August 29, 2024
概括
系统性硬化可以导致心力衰竭. 在患有硬化肌肉性心肌炎的患者中,友透管端到端修复 (M-TEER) 成功治疗了严重的腹腔功能性友反,改善了心脏功能.
科学领域:
- 心脏病学 心脏病学
- 类风湿病学 类风湿病学
- 医疗干预 医疗干预
背景情况:
- 系统性硬化症经常涉及心脏表现,尽管心肌炎并不常见.
- 有限的数据存在于由于硬化肌肌性心肌炎的腹腔功能性腹腔反 (vFMR) 的 mitra transcatheter 边缘到边缘修复 (M-TEER).
研究的目的:
- 报告第一个M-TEER病例的严重vFMR继发于硬化肌皮性心肌炎.
- 在这种特定的临床背景下,评估M-TEER在治疗心力衰竭方面的疗效.
主要方法:
- 一个79岁的男性病例报告,患有有限的皮肤系统性硬化和心力衰竭.
- 通过显示淋巴细胞透的内心肌细胞活检证实了诊断.
- 治疗涉及严重vFMR的M-TEER,其次是免疫抑制疗法.
主要成果:
- 该患者出现了心力衰竭症状,并被诊断出患有硬化硬质肌性心肌炎.
- M-TEER显著降低了额头回体积和改善了心力衰竭症状.
- 术后开始免疫抑制疗法,导致病情稳定.
结论:
- 硬化硬化肌性心肌炎可能导致心力衰竭,排气率降低和严重的vFMR.
- 在肌心炎引起的严重vFMR的情况下,M-TEER是血液动力稳定的一种可行的选择.
相关概念视频
Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Healing II: Complications
Complications during healing arise when tissue repair is altered by local or systemic factors. These changes involve abnormal collagen deposition, altered biomechanics, and reduced vascular supply, impairing restoration of normal structure and function.Loss of FunctionScar tissue differs significantly from the original tissue it replaces. In the skin, fibrosis lacks adnexal structures such as hair follicles, sebaceous glands, and sweat glands. Their absence reduces tactile sensitivity, impairs...


